CN Stock MarketDetailed Quotes

688091 Shanghai Yizhong Pharmaceutical

Watchlist
  • 39.84
  • -0.16-0.40%
Market Closed Dec 27 15:00 CST
8.23BMarket Cap125.28P/E (TTM)

Shanghai Yizhong Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-19.58%651.13M
-64.61%267.51M
26.83%974.25M
28.77%914.76M
17.50%809.63M
17.48%755.85M
168.47%768.13M
543.28%710.38M
12.87%689.06M
289,563.08%643.4M
Transactional financial assets
-99.05%3.01M
41.89%460.71M
-5.72%305.33M
-3.98%325.42M
-8.75%315.88M
1.61%324.7M
-51.35%323.87M
-59.30%338.9M
1.32%346.16M
1,257.49%319.55M
Notes receivable and accounts receivable
-16.42%117.96M
21.77%138.97M
89.07%134.5M
237.26%143.12M
310.13%141.13M
252.50%114.13M
302.88%71.14M
933.83%42.44M
--34.41M
--32.38M
-Notes receivable
-85.17%1.11M
----
--136.46K
--136.46K
--7.49M
--102.25K
----
----
----
----
-Accounts receivable
-12.56%116.85M
21.88%138.97M
88.87%134.36M
236.94%142.98M
288.36%133.63M
252.19%114.03M
302.88%71.14M
933.83%42.44M
--34.41M
--32.38M
Other receivables (including interest and dividends)
189.76%5.46M
340.16%5.33M
450.19%3.1M
54.30%46.62K
848.24%1.89M
64.59%1.21M
368.58%563.7K
695.11%30.21K
491.60%198.8K
2,248.88%735.2K
-Other receivable
----
340.16%5.33M
----
54.30%46.62K
----
64.59%1.21M
----
695.11%30.21K
----
2,248.88%735.2K
Advance payment
378.76%8.74M
-59.02%4.48M
-64.83%4.16M
-91.30%929.58K
-85.20%1.82M
2.13%10.93M
-55.34%11.84M
-9.64%10.68M
-10.08%12.33M
-50.15%10.7M
Inventories
16.79%30.18M
102.00%30.51M
90.07%30.24M
66.50%28.41M
68.46%25.84M
-24.31%15.1M
-0.98%15.91M
44.81%17.06M
40.92%15.34M
1,665.09%19.96M
Receivable financing
--575.34K
----
----
--28.03K
----
----
----
----
----
----
Other current assets
-52.00%28.77M
-92.84%4.99M
-96.75%2.27M
-99.33%534.18K
390.21%59.93M
562.47%69.75M
576.20%69.87M
487.80%80.22M
15.73%12.22M
0.60%10.53M
Total current assets
-37.63%845.82M
-29.35%912.5M
15.26%1.45B
17.80%1.41B
22.20%1.36B
24.53%1.29B
23.35%1.26B
20.75%1.2B
11.35%1.11B
1,596.03%1.04B
Non Current assets
Fixed assets
----
40.13%111.44M
----
40.72%115.41M
----
-2.15%79.53M
----
-0.43%82.01M
----
-4.45%81.27M
Constru in process
----
-79.77%8.81M
----
-87.81%4.81M
----
241.15%43.55M
----
2,391.53%39.44M
----
2,125.70%12.77M
Intangible assets
-2.51%8.42M
-2.49%8.47M
-2.47%8.52M
-2.46%8.58M
-2.44%8.63M
-2.43%8.69M
-2.41%8.74M
-2.40%8.79M
-2.39%8.85M
-2.37%8.9M
Long deferred expense
42.09%2.63M
-15.79%1.64M
26.39%1.75M
735.36%1.86M
--1.85M
--1.95M
--1.39M
--222.57K
----
----
Deferred tax assets
69.44%7.71M
114.27%7.07M
221.07%6.29M
206.47%5.65M
-29.89%4.55M
-48.80%3.3M
-68.65%1.96M
-69.65%1.84M
--6.49M
--6.45M
Other non current assets
2,113.77%486.95M
2,052.28%485.65M
-0.60%23.9M
5.53%23.82M
-75.79%22M
-78.18%22.56M
-75.06%24.04M
-79.10%22.57M
-13.65%90.87M
-1.19%103.39M
Total non current assets
300.83%642.26M
290.45%623.08M
3.26%161.86M
3.38%160.12M
-27.18%160.23M
-25.00%159.58M
-19.36%156.75M
-25.18%154.88M
10.98%220.04M
6.67%212.78M
Total assets
-1.86%1.49B
5.81%1.54B
13.94%1.62B
16.15%1.57B
14.03%1.52B
16.10%1.45B
16.53%1.42B
12.83%1.35B
11.29%1.33B
379.63%1.25B
Liabilities
Current liabilities
Short term loan
-45.74%10.91M
--31.02M
--53.1M
--44.03M
--20.1M
----
----
----
----
----
Notes payable and accounts payable
-11.73%23.5M
-7.74%29.65M
185.46%40.24M
75.04%37.7M
-24.77%26.62M
863.20%32.14M
467.57%14.1M
1,829.67%21.53M
378.18%35.38M
198.49%3.34M
-Accounts payable
-11.73%23.5M
-7.74%29.65M
185.46%40.24M
75.04%37.7M
-24.77%26.62M
863.20%32.14M
467.57%14.1M
1,829.67%21.53M
378.18%35.38M
198.49%3.34M
Contract liabilities
-95.01%596.89K
10.44%790.15K
175.09%914.57K
810.78%1.11M
4,271.51%11.96M
255.07%715.46K
--332.47K
--121.94K
--273.49K
--201.5K
Salaries payable
-37.50%9.66M
-0.06%6.96M
8.34%5.63M
93.66%5.97M
144.31%15.46M
63.73%6.96M
102.54%5.2M
109.41%3.08M
116.79%6.33M
103.00%4.25M
Taxs payable
-78.83%1.78M
-84.46%1.92M
0.98%11.79M
274.64%13.12M
109.85%8.41M
548.98%12.36M
5,484.07%11.68M
847.80%3.5M
858.20%4.01M
807.56%1.9M
Other payable (including interest and dividends)
-60.21%516.99K
108.09%961.11K
27.68%783.47K
26.17%2.05M
2.49%1.3M
-48.14%461.88K
1.66%613.61K
16.24%1.62M
-9.46%1.27M
-62.37%890.6K
-Other payable
----
108.09%961.11K
----
26.17%2.05M
----
-48.14%461.88K
----
16.24%1.62M
----
-62.37%890.6K
Other current liabilities
----
----
-96.34%196.85
1,297.97%16.13K
5,963.41%344.28K
132.09%13.18K
--5.38K
--1.15K
--5.68K
--5.68K
Total current liabilities
-44.22%46.96M
35.43%71.3M
252.28%112.47M
248.19%103.98M
78.12%84.19M
397.15%52.65M
315.53%31.93M
41.51%29.86M
47.08%47.27M
-58.94%10.59M
Current liabilities
Deferred tax liabilities
-12.68%2.8M
-11.57%2.97M
-8.09%2.99M
-5.97%3.07M
1,010.33%3.21M
1,516.70%3.36M
6,273.58%3.25M
315.66%3.26M
--288.91K
--208.09K
Long term deferred income
-31.22%1.14M
-33.24%1.24M
-34.73%1.35M
-35.74%1.47M
-33.86%1.65M
-31.21%1.86M
-28.96%2.08M
-27.00%2.29M
-25.29%2.5M
-23.79%2.71M
Total non current liabilities
-18.98%3.94M
-19.30%4.22M
-18.47%4.34M
-18.23%4.54M
74.37%4.86M
79.17%5.23M
79.18%5.33M
41.68%5.55M
-16.65%2.79M
-17.94%2.92M
Total liabilities
-42.84%50.9M
30.48%75.52M
213.57%116.81M
206.43%108.52M
77.91%89.05M
328.46%57.88M
249.60%37.25M
41.54%35.42M
41.07%50.05M
-53.97%13.51M
Shareholders equity
Paid-in capital
30.00%205.76M
30.00%205.76M
10.00%158.28M
10.00%158.28M
49.60%158.28M
49.60%158.28M
36.00%143.89M
36.00%143.89M
0.00%105.8M
33.33%105.8M
Capital reserve funds
-2.46%1.04B
-2.24%1.03B
1.05%1.08B
1.22%1.07B
-2.83%1.07B
-3.51%1.06B
-2.80%1.07B
-3.40%1.06B
0.00%1.1B
487.14%1.1B
Surplus reserve funds
138.88%27.82M
138.88%27.82M
138.88%27.82M
138.88%27.82M
--11.65M
--11.65M
--11.65M
--11.65M
----
----
Retained profit
0.19%192.47M
16.13%192.3M
47.83%236.04M
97.67%206.86M
147.54%192.1M
381.11%165.59M
3,716.80%159.67M
493.99%104.65M
281.80%77.61M
198.93%34.42M
Less:Treasury stock
--27.94M
----
----
----
----
----
----
----
----
----
Shareholders equity without minority interests
0.69%1.44B
4.79%1.46B
8.55%1.5B
11.04%1.46B
11.53%1.43B
12.68%1.39B
14.47%1.38B
12.22%1.32B
10.38%1.28B
434.64%1.24B
Total shareholder equity
0.69%1.44B
4.79%1.46B
8.55%1.5B
11.04%1.46B
11.53%1.43B
12.68%1.39B
14.47%1.38B
12.22%1.32B
10.38%1.28B
434.64%1.24B
Total liabilityies and equity
-1.86%1.49B
5.81%1.54B
13.94%1.62B
16.15%1.57B
14.03%1.52B
16.10%1.45B
16.53%1.42B
12.83%1.35B
11.29%1.33B
379.63%1.25B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -19.58%651.13M-64.61%267.51M26.83%974.25M28.77%914.76M17.50%809.63M17.48%755.85M168.47%768.13M543.28%710.38M12.87%689.06M289,563.08%643.4M
Transactional financial assets -99.05%3.01M41.89%460.71M-5.72%305.33M-3.98%325.42M-8.75%315.88M1.61%324.7M-51.35%323.87M-59.30%338.9M1.32%346.16M1,257.49%319.55M
Notes receivable and accounts receivable -16.42%117.96M21.77%138.97M89.07%134.5M237.26%143.12M310.13%141.13M252.50%114.13M302.88%71.14M933.83%42.44M--34.41M--32.38M
-Notes receivable -85.17%1.11M------136.46K--136.46K--7.49M--102.25K----------------
-Accounts receivable -12.56%116.85M21.88%138.97M88.87%134.36M236.94%142.98M288.36%133.63M252.19%114.03M302.88%71.14M933.83%42.44M--34.41M--32.38M
Other receivables (including interest and dividends) 189.76%5.46M340.16%5.33M450.19%3.1M54.30%46.62K848.24%1.89M64.59%1.21M368.58%563.7K695.11%30.21K491.60%198.8K2,248.88%735.2K
-Other receivable ----340.16%5.33M----54.30%46.62K----64.59%1.21M----695.11%30.21K----2,248.88%735.2K
Advance payment 378.76%8.74M-59.02%4.48M-64.83%4.16M-91.30%929.58K-85.20%1.82M2.13%10.93M-55.34%11.84M-9.64%10.68M-10.08%12.33M-50.15%10.7M
Inventories 16.79%30.18M102.00%30.51M90.07%30.24M66.50%28.41M68.46%25.84M-24.31%15.1M-0.98%15.91M44.81%17.06M40.92%15.34M1,665.09%19.96M
Receivable financing --575.34K----------28.03K------------------------
Other current assets -52.00%28.77M-92.84%4.99M-96.75%2.27M-99.33%534.18K390.21%59.93M562.47%69.75M576.20%69.87M487.80%80.22M15.73%12.22M0.60%10.53M
Total current assets -37.63%845.82M-29.35%912.5M15.26%1.45B17.80%1.41B22.20%1.36B24.53%1.29B23.35%1.26B20.75%1.2B11.35%1.11B1,596.03%1.04B
Non Current assets
Fixed assets ----40.13%111.44M----40.72%115.41M-----2.15%79.53M-----0.43%82.01M-----4.45%81.27M
Constru in process -----79.77%8.81M-----87.81%4.81M----241.15%43.55M----2,391.53%39.44M----2,125.70%12.77M
Intangible assets -2.51%8.42M-2.49%8.47M-2.47%8.52M-2.46%8.58M-2.44%8.63M-2.43%8.69M-2.41%8.74M-2.40%8.79M-2.39%8.85M-2.37%8.9M
Long deferred expense 42.09%2.63M-15.79%1.64M26.39%1.75M735.36%1.86M--1.85M--1.95M--1.39M--222.57K--------
Deferred tax assets 69.44%7.71M114.27%7.07M221.07%6.29M206.47%5.65M-29.89%4.55M-48.80%3.3M-68.65%1.96M-69.65%1.84M--6.49M--6.45M
Other non current assets 2,113.77%486.95M2,052.28%485.65M-0.60%23.9M5.53%23.82M-75.79%22M-78.18%22.56M-75.06%24.04M-79.10%22.57M-13.65%90.87M-1.19%103.39M
Total non current assets 300.83%642.26M290.45%623.08M3.26%161.86M3.38%160.12M-27.18%160.23M-25.00%159.58M-19.36%156.75M-25.18%154.88M10.98%220.04M6.67%212.78M
Total assets -1.86%1.49B5.81%1.54B13.94%1.62B16.15%1.57B14.03%1.52B16.10%1.45B16.53%1.42B12.83%1.35B11.29%1.33B379.63%1.25B
Liabilities
Current liabilities
Short term loan -45.74%10.91M--31.02M--53.1M--44.03M--20.1M--------------------
Notes payable and accounts payable -11.73%23.5M-7.74%29.65M185.46%40.24M75.04%37.7M-24.77%26.62M863.20%32.14M467.57%14.1M1,829.67%21.53M378.18%35.38M198.49%3.34M
-Accounts payable -11.73%23.5M-7.74%29.65M185.46%40.24M75.04%37.7M-24.77%26.62M863.20%32.14M467.57%14.1M1,829.67%21.53M378.18%35.38M198.49%3.34M
Contract liabilities -95.01%596.89K10.44%790.15K175.09%914.57K810.78%1.11M4,271.51%11.96M255.07%715.46K--332.47K--121.94K--273.49K--201.5K
Salaries payable -37.50%9.66M-0.06%6.96M8.34%5.63M93.66%5.97M144.31%15.46M63.73%6.96M102.54%5.2M109.41%3.08M116.79%6.33M103.00%4.25M
Taxs payable -78.83%1.78M-84.46%1.92M0.98%11.79M274.64%13.12M109.85%8.41M548.98%12.36M5,484.07%11.68M847.80%3.5M858.20%4.01M807.56%1.9M
Other payable (including interest and dividends) -60.21%516.99K108.09%961.11K27.68%783.47K26.17%2.05M2.49%1.3M-48.14%461.88K1.66%613.61K16.24%1.62M-9.46%1.27M-62.37%890.6K
-Other payable ----108.09%961.11K----26.17%2.05M-----48.14%461.88K----16.24%1.62M-----62.37%890.6K
Other current liabilities ---------96.34%196.851,297.97%16.13K5,963.41%344.28K132.09%13.18K--5.38K--1.15K--5.68K--5.68K
Total current liabilities -44.22%46.96M35.43%71.3M252.28%112.47M248.19%103.98M78.12%84.19M397.15%52.65M315.53%31.93M41.51%29.86M47.08%47.27M-58.94%10.59M
Current liabilities
Deferred tax liabilities -12.68%2.8M-11.57%2.97M-8.09%2.99M-5.97%3.07M1,010.33%3.21M1,516.70%3.36M6,273.58%3.25M315.66%3.26M--288.91K--208.09K
Long term deferred income -31.22%1.14M-33.24%1.24M-34.73%1.35M-35.74%1.47M-33.86%1.65M-31.21%1.86M-28.96%2.08M-27.00%2.29M-25.29%2.5M-23.79%2.71M
Total non current liabilities -18.98%3.94M-19.30%4.22M-18.47%4.34M-18.23%4.54M74.37%4.86M79.17%5.23M79.18%5.33M41.68%5.55M-16.65%2.79M-17.94%2.92M
Total liabilities -42.84%50.9M30.48%75.52M213.57%116.81M206.43%108.52M77.91%89.05M328.46%57.88M249.60%37.25M41.54%35.42M41.07%50.05M-53.97%13.51M
Shareholders equity
Paid-in capital 30.00%205.76M30.00%205.76M10.00%158.28M10.00%158.28M49.60%158.28M49.60%158.28M36.00%143.89M36.00%143.89M0.00%105.8M33.33%105.8M
Capital reserve funds -2.46%1.04B-2.24%1.03B1.05%1.08B1.22%1.07B-2.83%1.07B-3.51%1.06B-2.80%1.07B-3.40%1.06B0.00%1.1B487.14%1.1B
Surplus reserve funds 138.88%27.82M138.88%27.82M138.88%27.82M138.88%27.82M--11.65M--11.65M--11.65M--11.65M--------
Retained profit 0.19%192.47M16.13%192.3M47.83%236.04M97.67%206.86M147.54%192.1M381.11%165.59M3,716.80%159.67M493.99%104.65M281.80%77.61M198.93%34.42M
Less:Treasury stock --27.94M------------------------------------
Shareholders equity without minority interests 0.69%1.44B4.79%1.46B8.55%1.5B11.04%1.46B11.53%1.43B12.68%1.39B14.47%1.38B12.22%1.32B10.38%1.28B434.64%1.24B
Total shareholder equity 0.69%1.44B4.79%1.46B8.55%1.5B11.04%1.46B11.53%1.43B12.68%1.39B14.47%1.38B12.22%1.32B10.38%1.28B434.64%1.24B
Total liabilityies and equity -1.86%1.49B5.81%1.54B13.94%1.62B16.15%1.57B14.03%1.52B16.10%1.45B16.53%1.42B12.83%1.35B11.29%1.33B379.63%1.25B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Top CN Stock Gainers
Symbol Price % Chg
Suzhou Industrial Park Heshun Electric
300141
11.14 +20.04%
Guangdong Xiongsu Technology Group
300599
7.67 +20.03%
Sichuan Chuanhuan Technology
300547
24.41 +20.01%
Shanghai Wisdom Information Technology
301315
65.82 +20.00%
KANGNONG SEED
837403
22.69 +19.86%

See the daily top gainer.

Investment Theme Innovative Drugs
Innovative Drugs
Intraday+0.47%